Langone

Redfin Report: Buyers Can’t Buy if Sellers Won’t Sell

Retrieved on: 
Thursday, April 13, 2023
Professional Services, Technology, Other Construction & Property, Residential Building & Real Estate, Finance, Construction & Property, Internet, Fed, Housing, Sale, Data, Yoy, Pique, Langone, Real estate, Cryptocurrency, Video game, Tunnel, Retail, Easter

People are reluctant to sell because they don’t want to give up their low mortgage rate and it’s hard to find another home to buy.

Key Points: 
  • People are reluctant to sell because they don’t want to give up their low mortgage rate and it’s hard to find another home to buy.
  • While pending sales are down, early-stage homebuying demand is ticking up, with mortgage-purchase applications up 8% from a week earlier, seasonally adjusted.
  • Angela Langone , a Redfin agent in San Jose, said there aren’t enough listings to go around, with multiple offers on many homes.
  • “Many buyers here aren’t held back by high mortgage rates; it’s the lack of inventory that’s really getting in their way,” Langone said.

Charlotte's Web forms Joint Venture with BAT and AJNA BioSciences to Seek FDA-Approval for Proprietary Full Spectrum Hemp Extract Botanical Drug

Retrieved on: 
Thursday, April 6, 2023
Charlotte's Web, Epilepsy, BAT, LSE, Indian stock exchange, CW, Nicotine, MI, Genetics, Lennox–Gastaut syndrome, NYU, DSM-IV codes, Cannabinoid, New York University Grossman School of Medicine, Effective interest rate, CWEB, Research, Tobacco, Joint venture, JV, US, Investigational New Drug, National Association of Epilepsy Centers, Natural American Spirit, Transaction, Psychiatry, Cannabis, Drug development, TSX, Commercial, FDA, Langone, American Tobacco Company, Mental health, IND, News, NYSE, BTI, Pharmaceutical industry, Security (finance), New York University, Neurology, Neurosurgery

This novel botanical drug will be developed from certain proprietary hemp genetics of CW.

Key Points: 
  • This novel botanical drug will be developed from certain proprietary hemp genetics of CW.
  • The JV plans to engage with the FDA to file an Investigational New Drug ("IND") application and commence Phase I clinical development in 2023.
  • The JV plans to use the initial US$10 million investment for the clinical development of a novel hemp botanical IND.
  • I believe the properties of cannabis and hemp are well suited for the FDA's new Botanical Drug Development pathway", Dr. Devinsky said.

NYU Stern’s Langone Part-Time MBA Program Receives $25 Million Testamentary Gift from its Naming Benefactor

Retrieved on: 
Thursday, January 26, 2023
Other Professional Services, Business, Military, Veterans, Other Education, Professional Services, Other Philanthropy, Continuing, Philanthropy, Defense, University, Education, Fund Raising, Foundation, Online, MBA, Alumni, Trustee, U.S. News & World Report, New York University Stern School of Business, Academic acceleration, News, The Home Depot, American Dream, New York University, NYU, Dream, NYU Langone Health, Langone, BS, Management

Today, New York University Stern School of Business announced a new $25 million testamentary gift from alumnus and Stern Executive Board member Kenneth G. Langone (MBA ’60) and his wife, Elaine, for scholarships to support the School’s Langone Part-Time MBA Program, especially military veterans and active-duty military personnel in the program.

Key Points: 
  • Today, New York University Stern School of Business announced a new $25 million testamentary gift from alumnus and Stern Executive Board member Kenneth G. Langone (MBA ’60) and his wife, Elaine, for scholarships to support the School’s Langone Part-Time MBA Program, especially military veterans and active-duty military personnel in the program.
  • A Co-founder of Home Depot, and the Founder and CEO of Invemed Associates, Mr. Langone donated $10 million to Stern in 1999, at which time the part-time MBA was named in his honor.
  • Langone students can choose one of four academic options, based on their individual needs, to pursue their MBA: Weeknights, Saturday, Accelerated Two-Year, or the new Online/Modular Option.
  • Ken and Elaine’s gift will help the next generation of leaders make their hopes and dreams a reality.”

Cardiac And Pulmonary Wellness & Rehabilitation Expert Dr. Noah Greenspan Joins Exclusive Haute Beauty Network

Retrieved on: 
Wednesday, January 12, 2022
Online, Research, Rehabilitation, EMT, Flight length, The Cancer Prevention and Education Society, PT, Idiopathic pulmonary fibrosis, COVID-19, Chronic obstructive pulmonary disease, Drug, Survivor, Physical medicine and rehabilitation, COPD, Safety, PWF, CCS, Beauty, Student, High, DPT, Caregiver, Rusk Institute of Rehabilitation Medicine, IPF, Haute Living, Staten Island University Hospital, Diagnosis, Clothing, New York Medical College, Center, Coronavirus, H&D, Exercise, New York University Grossman School of Medicine, Niagara Falls Memorial Medical Center, Pulmonary hypertension, Advanced cardiac life support, Long Island University, Ultimate, Dominican College, Efficacy, Faculty, Impact, COVID, Hospital, Pharmaceutical industry, Medicine, Fashion, New York University, Patient, Cardiology, MD, Langone

Noah Greenspan began his professional career at the New York University (now Langone) Medical Center's Rusk Institute of Rehabilitation Medicine, with clinical rotations in medical, surgical, orthopedic, and neurologic rehabilitation, chest physical therapy and ultimately cardiovascular and pulmonary rehabilitation.

Key Points: 
  • Noah Greenspan began his professional career at the New York University (now Langone) Medical Center's Rusk Institute of Rehabilitation Medicine, with clinical rotations in medical, surgical, orthopedic, and neurologic rehabilitation, chest physical therapy and ultimately cardiovascular and pulmonary rehabilitation.
  • In 1998, he founded the Pulmonary Wellness & Rehabilitation Center, a Manhattan-based physical therapy practice specializing in the care of patients with cardiovascular, pulmonary, and complex medical conditions.
  • As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
  • For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/
    Brooke Klaiman, Haute Beauty by Haute Living, 5612122126, [email protected]

NYU Stern Announces New Online/Modular Option for Part-time MBA Program

Retrieved on: 
Tuesday, November 16, 2021
Education, Technology, Continuing, Internet, Training, University, Online, New York University Stern School of Business, Student, New York University, Culture, Government, Organization, Heart, MBA, Curriculum, Langone, Program, Vocational school, Xavier University MBA Program, City, Faculty, Hope, NYU, Time, Lists of schools in England, Management

We recognize that one size does not fit all and hope to be giving students more innovative ways to customize their MBA experience, said Raghu Sundaram, Dean, NYU Stern.

Key Points: 
  • We recognize that one size does not fit all and hope to be giving students more innovative ways to customize their MBA experience, said Raghu Sundaram, Dean, NYU Stern.
  • Stern has an established strength in delivering quality with flexibility, from the legacy of our Part-time MBA Program, to the successful launch of our online MS in Quantitative Management Program a few year ago, to introducing an online option for select courses in the past year, said JP Eggers, Vice Dean of MBA and Graduate Programs, NYU Stern.
  • Students can select the Online/Modular option on their application, which opens today for the Fall 2022 program start.
  • NYU Stern is a welcoming community that inspires its members to embrace and lead change in a rapidly transforming world.

NYU Langone Presentations At American College Of Rheumatology Convergence 2021 To Address Vaccine Efficacy And High-Risk Pregnancy

Retrieved on: 
Monday, November 1, 2021
Safety, Woman, Sjögren syndrome, Death, HCQ, MD, Research, Lupus, Arthritis, 2021 Essex County Council election, New York University Grossman School of Medicine, Immunosuppression, Mother, Heart rate, ACR, U.S. News & World Report, Antimalarial medication, Vaccination, Birth defect, Transesophageal echocardiogram, Joint Medical Service (Germany), Colorado EKG Repository, Patient, Blood, Faculty, SLE, NYU Langone Health, Degenerative disease, Antibody, Severe acute respiratory syndrome coronavirus 2, American College of Rheumatology, CHB, QT interval, Risk, Medicine, Chronic kidney disease, Physician, Immunoglobulin G, COVID-19, CKD, American College, Joint, Hydroxychloroquine, Congenital heart block, News, Hope, Division, Autoimmunity, COVID, NYU, Langone, Pharmaceutical industry, Management, Medical imaging

NEW YORK, Nov. 1, 2021 /PRNewswire/ --NYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9.

Key Points: 
  • NEW YORK, Nov. 1, 2021 /PRNewswire/ --NYU Langone rheumatologists are presenting their discoveries at the annual American College of Rheumatology conference, November 1 to November 9.
  • Topics presented will include COVID-19 vaccine efficacy in lupus patients, fetal heart rate monitoring in high-risk pregnancies, and the relationship between whole blood levels of hydroxychloroquine and cardiac risks.
  • "Our clinicians and researchers are excited to share their work with the rheumatology community, and to open the doors for further study."
  • At this year's meeting, NYU Langone rheumatologists are presenting more than 40 posters, abstracts, summits, and scientific sessions.

The Family Health Centers at NYU Langone Receives $2 Million CDC Grant to Expand Effective HIV Prevention

Retrieved on: 
Wednesday, August 4, 2021
New York University, Midtown Manhattan, NYU Langone Health, Langone, Prevention of HIV/AIDS, Manhattan, New York City

BROOKLYN, N.Y., Aug. 4, 2021 /PRNewswire/ -- Affirming the success of its HIV prevention programs and support strategies, the Family Health Centers at NYU Langone has received an additional five-year, $2 million grant through the Centers for Disease Control and Prevention's (CDC) Comprehensive High-Impact HIV Prevention Programs for Community Based Organizations.

Key Points: 
  • BROOKLYN, N.Y., Aug. 4, 2021 /PRNewswire/ -- Affirming the success of its HIV prevention programs and support strategies, the Family Health Centers at NYU Langone has received an additional five-year, $2 million grant through the Centers for Disease Control and Prevention's (CDC) Comprehensive High-Impact HIV Prevention Programs for Community Based Organizations.
  • "This competitive grant validates the progress and potential of our outreach efforts to prevent HIV and support our community," says Larry K. McReynolds , executive director of the Family Health Centers at NYU Langone and clinical associate professor in the Department of Population Health at NYU Grossman School of Medicine.
  • "For more than 30 years, the Family Health Centers at NYU Langone has been at the forefront of HIV care and prevention," says Finn Schubert, network HIV program director at the Family Health Centers at NYU Langone.
  • HIV prevention partnership with Turning Point Brooklyn , which provides education, housing, and related servicesin the Sunset Park, Brooklyn, community.

FDA Clears NYU Langone Genome PACT

Retrieved on: 
Thursday, July 29, 2021
New York University, Midtown Manhattan, NYU Langone Health, Cancer, Langone

Cleared by the agency on July 15, 2021, under its 510(k) designation, the NYU Langone Genome PACT (Profiling of Actionable Cancer Targets) test detects changes in the DNA code of 607 genes linked by past studies to the development of multiple types of cancer.

Key Points: 
  • Cleared by the agency on July 15, 2021, under its 510(k) designation, the NYU Langone Genome PACT (Profiling of Actionable Cancer Targets) test detects changes in the DNA code of 607 genes linked by past studies to the development of multiple types of cancer.
  • "The FDA decision on PACTreaffirms the goal behind its design, which was to provide our patients with the best understanding of the genetic changes driving their cancers," says PACT designer Matija Snuderl, MD , director of Molecular Pathology and Diagnostics in the Department of Pathology at NYU Langone Health.
  • The PACT effort has already revealed genetic alterations (novel variants) that may be important to cancers, with the results validated by the NYU Genome Technology Center led by Adriana Heguy, PhD , assistant dean for Advanced Research Technologies.
  • The test is cleared for use by the FDA at this time only for use in patients of NYU Langone Health.

Michael R. Scoma is recognized by Continental Who's Who

Retrieved on: 
Thursday, July 1, 2021
New York University, Midtown Manhattan, NYU Langone Health, Infectious disease, Mineola, New York, Langone, Infection

MINEOLA, N.Y., July 1, 2021 /PRNewswire/ -- Michael R. Scoma is being recognized by Continental Who's Who as a Top Infectious Disease Specialist for his years of dedicated work in the field.

Key Points: 
  • MINEOLA, N.Y., July 1, 2021 /PRNewswire/ -- Michael R. Scoma is being recognized by Continental Who's Who as a Top Infectious Disease Specialist for his years of dedicated work in the field.
  • With over seventeen years of experience, Dr. Scoma is well versed in Infectious Disease treatment and care.
  • As an infectious disease specialist at NYU Langone Hospital in Long Island and his practice Scoma Medical Group PLLC, Dr. Scoma treats all patients with care and compassion.
  • As the founder of Scoma Medical Group PLLC, Dr. Scoma currently practices at 173 Mineola Boulevard, Suite 401A.

New Center for Higher Ambition Leadership CEO Jeannie Diefenderfer Shares Bold Vision to Increase Reach and Impact of the Nonprofit

Retrieved on: 
Tuesday, June 1, 2021
New York University, Langone, NetScout Systems, NYU Langone Health, Manhattan

As CEO, Diefenderfer will represent CHL with business leaders, cultivate relationships and partnerships for the organization, and strategically expand programming to align with evolving member priorities.

Key Points: 
  • As CEO, Diefenderfer will represent CHL with business leaders, cultivate relationships and partnerships for the organization, and strategically expand programming to align with evolving member priorities.
  • Members include BD, Boston Scientific, Henry Schein, NETSCOUT, NYU Langone Health, Pacific Dental Services, Quest Diagnostics, United Rentals, and Xylem.
  • Board Chair Doug Conant established the CHL Chair Advisory Council to help the non-profit community increase its reach and impact with purpose-driven leaders, their organizations and their stakeholders around the world.
  • The Center for Higher Ambition Leadership is a not-for-profit community of leaders committed to building high-performing organizations that deliver superior economic and social value.